Our clinical genome sequencing services are run within our CLIA-certified, CAP-accredited laboratory, harnessing the advanced capabilities of next-generation short-read and long-read sequencing technology. These tests enable clinicians to obtain a complete picture of the genome, including complex variants and difficult-to-sequence regions.
These effective assays can help you tackle complex biological questions with complete genome data, fueling your innovations in precision medicine, biomarker discovery, and personalized therapies.
If you require more targeted genomic analyses for your clinical applications, explore our clinical whole exome sequencing services. We also offer research use only (RUO) whole genome sequencing for your non-clinical needs.
Submit DNA or blood sample
Sequencing on the Illumina short-read or PacBio long-read platforms
Receive raw data files and variant report
Service Level* | Data & Report (FASTQ, BAM & VCF) |
QA Oversight | Lab Director Signature |
Regulated Environment | |||
CLIA-Validated Service |
Included | Not Available
*All service levels are performed by CLIA-trained personnel in a CLIA-certified lab with CLIA-qualified equipment.
A biopharma company required a partner for clinical trial support with an immediate need for biomarker assay development and validation using NGS. Read the case study to learn how this company was able to streamline clinical testing and accelerate the timeline of its phase 1/2 study.